For a 68‑year‑old patient with type 2 diabetes, what is the best long‑acting insulin and what starting dose should be used?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Best Long-Acting Insulin and Starting Dose for a 68-Year-Old

For a 68-year-old patient with type 2 diabetes, initiate basal insulin at 10 units once daily or 0.1–0.2 units/kg/day, with long-acting analogs (glargine U-100, detemir, or degludec) preferred over NPH insulin due to lower hypoglycemia risk—a critical consideration in older adults. 1

Insulin Selection

First-Line Choice: Long-Acting Basal Analogs

The most recent ADA guidelines (2021-2025) consistently recommend long-acting basal insulin analogs as the preferred initial insulin regimen 2, 3. For a 68-year-old patient, the following options are appropriate:

  • Insulin glargine U-100
  • Insulin detemir
  • Insulin degludec (ultra-long-acting)
  • Insulin glargine U-300 (ultra-long-acting)

These analogs demonstrate reduced risk of symptomatic and nocturnal hypoglycemia compared to NPH insulin 2, which is particularly important in older adults where hypoglycemia poses greater risks for falls, cognitive impairment, and cardiovascular events 4.

Why Not NPH?

While NPH insulin remains a more affordable option 1, the modest cost savings must be weighed against the increased hypoglycemia risk in a 68-year-old patient. The longer-acting analogs (U-300 glargine or degludec) provide even lower nocturnal hypoglycemia risk than U-100 glargine 2, 3.

Starting Dose

Standard Initiation Protocol

Begin with one of two approaches 1:

  1. Fixed dose: 10 units once daily (simplest approach)
  2. Weight-based: 0.1–0.2 units/kg/day

For a 68-year-old, the 10-unit fixed starting dose is often preferred as it minimizes hypoglycemia risk and aligns with the "start low and go slow" principle essential in older adults 5.

Titration Strategy

Increase dose by 10–15% (or 2–4 units) once or twice weekly until fasting blood glucose targets are met 1. For older adults, the ADA recommends:

  • Fasting glucose target: 90–150 mg/dL (5.0–8.3 mmol/L) 4, 6
  • If ≥50% of fasting values exceed goal over one week: increase by 2 units
  • If >2 fasting values/week are <80 mg/dL: decrease by 2 units 4, 6

This is more liberal than targets for younger patients, reflecting the need to balance glycemic control with hypoglycemia avoidance in older adults.

Critical Considerations for Age 68

Individualized Glycemic Targets

At 68 years old, HbA1c targets should be individualized based on health status 4:

  • Healthy older adults (few comorbidities, intact cognition): HbA1c <7.0–7.5%
  • Complex/intermediate health: HbA1c <8.0%
  • Very complex/poor health: HbA1c <8.5%

Practical Implementation

Once-daily basal insulin is the most appropriate initial regimen for older adults 4, 5. It should be:

  • Combined with metformin (if not contraindicated and eGFR ≥45 mL/min) 1, 4
  • Administered at a consistent time daily (bedtime or morning)
  • Supported by patient education on glucose monitoring, hypoglycemia recognition, and injection technique 2, 1

Hypoglycemia Prevention

This is paramount in a 68-year-old patient. The evidence shows:

  • Insulin glargine reduces severe hypoglycemia risk by 32% vs. NPH (RR 0.68) 7
  • Insulin detemir reduces severe hypoglycemia risk by 55% vs. NPH (RR 0.45) 7
  • Serious hypoglycemia reduction with detemir: absolute risk reduction of 0.9% 7

Common Pitfalls to Avoid

  1. Overbasalization: Using excessively high basal insulin doses (typically >0.5 units/kg/day) without addressing postprandial hyperglycemia 3
  2. Aggressive titration: Increasing doses too rapidly in older adults increases hypoglycemia risk
  3. Ignoring functional status: Ensure the patient or caregiver can safely administer insulin and recognize hypoglycemia 4
  4. Using rapid-acting insulin at bedtime: This increases nocturnal hypoglycemia risk 4, 6

When to Advance Therapy

If basal insulin is optimally titrated (fasting glucose at goal) but HbA1c remains above target, consider 3:

  1. Adding a GLP-1 receptor agonist (preferred—reduces hypoglycemia and weight gain risk)
  2. Adding prandial insulin (if GLP-1 RA contraindicated or unavailable)

Do not advance therapy based solely on occasional elevated glucose values 8. Assess patterns over 1–2 weeks.

Dose Conversion Considerations

If switching between basal insulins 3:

  • Most conversions: Unit-for-unit, then adjust based on monitoring
  • From insulin detemir or U-300 glargine: Reduce initial dose by 10–20% to prevent hypoglycemia

References

5
Research

Insulin therapy in the elderly with type 2 diabetes.

Minerva endocrinologica, 2015

Related Questions

How do I calculate the appropriate dosing of Humulin 70/30 (human insulin) for an adult with type 2 diabetes?
How should I adjust my premixed 70/30 insulin (70% NPH, 30% regular) when my capillary blood glucose measured at 4 pm is elevated?
For a 47‑year‑old female with type 2 diabetes receiving high‑dose prednisone (140 mg at 8 am and 140 mg at 8 pm) during DA‑R‑EPOCH chemotherapy for stage 2 Burkitt lymphoma, currently on NPH 60 U at 8 am and 30 U at 8 pm with an insulin‑to‑carbohydrate ratio of 1 U per 6 g carbs and an insulin‑sensitivity factor of 25 mg/dL per U, and with capillary glucose readings of 218 mg/dL fasting, 245 mg/dL at noon, 242 mg/dL at 5 pm, 319 mg/dL at 6 pm, and 238 mg/dL overnight, what should the 8 am and 8 pm NPH doses be, and how should the insulin‑sensitivity factor and carbohydrate‑to‑insulin ratio be adjusted?
In a 53‑year‑old, 37‑kg woman with type 2 diabetes, insulin resistance, and a high‑carbohydrate diet, currently using insulin glargine (Lantus) 24 units daily, an insulin‑to‑carbohydrate ratio of 6 g per unit, and an insulin‑sensitivity factor of 25 mg/dL per unit, what should her insulin‑sensitivity factor, insulin‑to‑carbohydrate ratio, and basal insulin dose be adjusted to?
In a patient with overt diabetes mellitus, should insulin be started immediately?
Can an edematous ascitic decompensation raise pro‑BNP (pro‑B‑type natriuretic peptide) levels?
What is the appropriate dose of Benadryl (diphenhydramine) for a 15‑month‑old child weighing 12.15 kg?
In a patient with acute groin and hip pain after squatting 175 lb and a normal plain‑film radiograph showing no fracture, what is the most likely diagnosis and what is the recommended next step in management?
Is an oral contraceptive containing only norethindrone considered a progestin‑only pill?
Could acute groin and hip pain after a heavy squat with a normal plain‑film radiograph represent an avulsion injury?
In an otherwise healthy 1‑year‑old female with no fever or mucosal lesions, who presents with 2‑3 cm macular patches on each cheek and a small macular rash in the upper groin, and who had a mild conjunctival injection that resolved a week ago, is this likely a nonspecific viral exanthem?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.